Search For "pharma companies"
IT, oil and gas sectors show caution amid AI disruptions, West Asia confli
Updated : 1 week, 1 day ago IST
The IT services sector is facing challenges due to Artificial Intelligence (AI), with investors expressing concerns about job losses and the transition period. However, other sectors like real estate, autos, and domestic pharma companies showed more positive outlooks, with some showing stead
Read More
Morepen Bags Rs. 825 Crore Global Deal
Updated : 2 weeks, 5 days ago IST
Gurugram (Haryana) [India], February 23: Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) has secured a multi-year Contract Development and Manufacturing Organization (CDMO) mandate valued at approximately Rs. 825 crore (USD 91 million) from a leading global pharma major.
Read More
"Crucial moment for pharma industry": CSIR-CDRI Director Radha Rangarajan
Updated : 1 month, 1 week ago IST
CSIR-CDRI Director Radha Rangarajan, on Tuesday, stated the 'Uttar Pradesh Pharma Conclave 1.0' is one of the most crucial moments of the pharmaceutical industry and plays a major role in the industry's growth and expansion in the State.
Read More
Acintyo Leads India's First B2B2C Digital Pharmacy Revolution, Partners wi
Updated : 3 months ago IST
New Delhi [India], December 8: Acintyo Local, headquartered in Hyderabad, is India's first B2B2C digital medicine-delivery ecosystem that seamlessly connects pharma companies, suppliers, retailers, and consumers through an integrated technology platform. It empowers neighborhood pharmacies t
Read More
PharmaHopers India's Leading B2B Portal Expands Reach With Major Indian Ph
Updated : 5 months, 1 week ago IST
New Delhi [India], September 19: PharmaHopers has levelled up its B2B pharma portal and made it easier for clients to connect with India's top pharma companies. Once required, time-consuming searches and multiple touches have been transformed into just one click away. It brings India's top p
Read More
Any tariff on pharma will hit India, as 40% of its exports go to US: SBI R
Updated : 7 months, 1 week ago IST
Imposing tariffs on the pharmaceutical Industry will significantly impact the earnings of Indian pharma companies, as nearly 40 per cent of India's total pharma exports are directed to the US market
Read More
Indian CRDMOs benefiting from diversification by global pharmaceutical com
Updated : 8 months, 2 weeks ago IST
Indian CRDMOs (Contract Research and Development and Manufacturing Organizations) are seeing growing interest from global pharmaceutical companies, according to a recent report by Jefferies.
Read More
Trump's Executive Order on reducing prescription drug prices will have lim
Updated : 9 months, 1 week ago IST
Citing the reason behind its observation, the credit rating firm in its report said that despite India exporting over half of its pharmaceutical output, the bulk comprises low-priced generic drugs, which already operate on razor-thin margins, leaving little room for further price cuts to mat
Read More
Generic pharma companies unlikely to be impacted by Trump's order to cut R
Updated : 10 months ago IST
Generic drug companies in India are not expected to be affected by US President Donald Trump's new order to bring the prices for prescription (Rx) drugs in line with other developed nations, says a report by HDFC Securities.
Read More
Premas Life Sciences and Sphere Bio Unite to Advance Single-Cell Research
Updated : 10 months, 1 week ago IST
New Delhi [India], May 6: Premas Life Sciences Pvt. Ltd. (PLS), a pioneering enabler of life science innovations in India, has announced a strategic collaboration with Sphere Bio, a global leader in picodroplet-based microfluidic technologies for functional single-cell analysis. This partner
Read More
Pharma companies likely to see up to 16 pc sales growth in FY25: Centrum R
Updated : 11 months, 2 weeks ago IST
India's leading pharmaceutical companies are expected to report strong sales growth of up to 16 per cent year-on-year (YoY) in the financial year 2024-25, according to a report by Centrum Institutional Research.
Read More
US tariffs will have minimal impact on Indian pharma service companies lik
Updated : 1 year ago IST
Indian pharma companies like CDMOs (Contract Development and Manufacturing Organizations) will not see major disruptions from the proposed US tariffs of 10-25 per cent, according to a report by B&K Securities.
Read More